|Articles|May 1, 2017
- Pharmaceutical Executive-05-01-2017
- Volume 37
- Issue 5
Pharmaceutical Executive, May 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Brand of the Year: A Retrospectiveabout 9 years ago
Portfolio Management Health Checkabout 9 years ago
Launch for Long-Term Successabout 9 years ago
Merck’s Latest Shot Against Shinglesabout 9 years ago
Measuring the Value of Prescription Drugsabout 9 years ago
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quoabout 9 years ago
New Life in European Drug Pricing Spatabout 9 years ago
Country Report: SwitzerlandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5